COMPANY

Energesis Pharmaceuticals Inc.

HQ: Boston, MA source · energesispharma.com ↗ · New England

Keywords: metabolic obesity

Location: Boston, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

9NIH grants

NIH awards 9

Annual award amounts. Total $6.3M.

Jul 22, 2022 NIH award 5R44DK125193-03 FY2022: $969,884 awarded for that fiscal year; activity R44 (SBIR); PI BOSS, OLIVIER; recipient as written: ENERGESIS PHARMACEUTICALS, INC., BOSTON, MA. In Vivo Proof of Concept and Target I source ↗
Jul 20, 2021 NIH award 2R44DK125193-02 FY2021: $1,018,644 awarded for that fiscal year; activity R44 (SBIR); PI BOSS, OLIVIER; recipient as written: ENERGESIS PHARMACEUTICALS, INC., BOSTON, MA. In Vivo Proof of Concept and Target source ↗
Jun 30, 2020 NIH award 1R43DK125193-01A1 FY2020: $295,420 awarded for that fiscal year; activity R43 (SBIR); PI BOSS, OLIVIER; recipient as written: ENERGESIS PHARMACEUTICALS, INC., BOSTON, MA. Development of Novel Brown Adipocyt source ↗
Jul 24, 2018 NIH award 5R44DK113877-02 FY2018: $981,584 awarded for that fiscal year; activity R44 (SBIR); PI BOSS, OLIVIER; recipient as written: ENERGESIS PHARMACEUTICALS, INC., BOSTON, MA. Optimization and Pre-Clinical Studies source ↗
Sep 18, 2017 NIH award 1R44DK113877-01A1 FY2017: $793,958 awarded for that fiscal year; activity R44 (SBIR); PI BOSS, OLIVIER; recipient as written: ENERGESIS PHARMACEUTICALS, INC., BOSTON, MA. Optimization and Pre-Clinical Studi source ↗
Jun 29, 2017 NIH award 5R44DK109860-02 FY2017: $969,332 awarded for that fiscal year; activity R44 (SBIR); PI BOSS, OLIVIER; recipient as written: ENERGESIS PHARMACEUTICALS, INC., BOSTON, MA. Establishing In Vivo Proof of Concept source ↗
Jun 17, 2016 NIH award 1R44DK109860-01 FY2016: $812,187 awarded for that fiscal year; activity R44 (SBIR); PI BOSS, OLIVIER; recipient as written: ENERGESIS PHARMACEUTICALS, INC., BOSTON, MA. Establishing In Vivo Proof of Concept source ↗
Apr 18, 2014 NIH award 1R43DK101205-01 FY2014: $276,203 awarded for that fiscal year; activity R43 (SBIR); PI BOSS, OLIVIER; recipient as written: ENERGESIS PHARMACEUTICALS, INC., BOSTON, MA. Target Identification of Proteins and source ↗
Mar 25, 2013 NIH award 1R43DK099005-01 FY2013: $168,876 awarded for that fiscal year; activity R43 (SBIR); PI BOSS, OLIVIER; recipient as written: ENERGESIS PHARMACEUTICALS, INC., BOSTON, MA. Identifying Novel Targets for Recruit source ↗